• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物活性抗菌肽:对抗人畜共患病的新武器。

Bioactive Antimicrobial Peptides: A New Weapon to Counteract Zoonosis.

作者信息

Zupin Luisa, Santos-Silva Carlos André Dos, Al Mughrbi Aya R Hamad, Vilela Livia Maria Batista, Benko-Iseppon Ana Maria, Crovella Sergio

机构信息

Institute for Maternal and Child Health-IRCCS Burlo Garofolo, 34137 Trieste, Italy.

College of Dental Medicine, Qatar University, Doha 2713, Qatar.

出版信息

Microorganisms. 2022 Aug 7;10(8):1591. doi: 10.3390/microorganisms10081591.

DOI:10.3390/microorganisms10081591
PMID:36014009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9414035/
Abstract

Zoonoses have recently become the center of attention of the general population and scientific community. Notably, more than 30 new human pathogens have been identified in the last 30 years, 75% of which can be classified as zoonosis. The complete eradication of such types of infections is far out of reach, considering the limited understanding of animal determinants in zoonoses and their causes of emergence. Therefore, efforts must be doubled in examining the spread, persistence, and pathogenicity of zoonosis and studying possible clinical interventions and antimicrobial drug development. The search for antimicrobial bioactive compounds has assumed great emphasis, considering the emergence of multi-drug-resistant microorganisms. Among the biomolecules of emerging scientific interest are antimicrobial peptides (AMPs), potent biomolecules that can potentially act as important weapons against infectious diseases. Moreover, synthetic AMPs are easily tailored (bioinformatically) to target specific features of the pathogens to hijack, inducing no or very low resistance. Although very promising, previous studies on SAMPs' efficacy are still at their early stages. Indeed, further studies and better characterization on their mechanism of action with in vitro and in vivo assays are needed so as to proceed to their clinical application on human beings.

摘要

人畜共患病最近已成为普通民众和科学界关注的焦点。值得注意的是,在过去30年里已鉴定出30多种新的人类病原体,其中75%可归类为人畜共患病。考虑到对人畜共患病中动物决定因素及其出现原因的了解有限,彻底根除这类感染还远不可及。因此,必须加倍努力研究人畜共患病的传播、持续性和致病性,并研究可能的临床干预措施和抗菌药物开发。鉴于多重耐药微生物的出现,寻找具有抗菌活性的化合物已变得极为重要。新兴科学兴趣的生物分子中有抗菌肽(AMPs),这是一种有效的生物分子,有可能成为对抗传染病的重要武器。此外,合成抗菌肽很容易(通过生物信息学)进行定制,以针对病原体的特定特征进行靶向攻击,诱导无耐药性或极低的耐药性。尽管前景非常广阔,但此前关于合成抗菌肽功效的研究仍处于早期阶段。事实上,需要通过体外和体内试验对其作用机制进行进一步研究和更好的表征,以便将其应用于人类临床。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/0b809fb093f9/microorganisms-10-01591-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/1cb85952aae5/microorganisms-10-01591-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/5b79aad3bd9e/microorganisms-10-01591-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/0b809fb093f9/microorganisms-10-01591-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/1cb85952aae5/microorganisms-10-01591-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/5b79aad3bd9e/microorganisms-10-01591-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/043e/9414035/0b809fb093f9/microorganisms-10-01591-g003.jpg

相似文献

1
Bioactive Antimicrobial Peptides: A New Weapon to Counteract Zoonosis.生物活性抗菌肽:对抗人畜共患病的新武器。
Microorganisms. 2022 Aug 7;10(8):1591. doi: 10.3390/microorganisms10081591.
2
Important Roles and Potential Uses of Natural and Synthetic Antimicrobial Peptides (AMPs) in Oral Diseases: Cavity, Periodontal Disease, and Thrush.天然和合成抗菌肽(AMPs)在口腔疾病(龋齿、牙周病和鹅口疮)中的重要作用及潜在用途
J Funct Biomater. 2022 Oct 3;13(4):175. doi: 10.3390/jfb13040175.
3
Synthetic antimicrobial peptides: Characteristics, design, and potential as alternative molecules to overcome microbial resistance.合成抗菌肽:特性、设计及其作为克服微生物耐药性替代分子的潜力。
Life Sci. 2021 Aug 1;278:119647. doi: 10.1016/j.lfs.2021.119647. Epub 2021 May 24.
4
Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds.抗菌肽 (AMPs):一类有前景的抗菌化合物。
J Appl Microbiol. 2022 Mar;132(3):1573-1596. doi: 10.1111/jam.15314. Epub 2021 Oct 13.
5
Evaluation of Antimicrobial Peptides from the Black Soldier Fly () against a Selection of Human Pathogens.黑皮蠹()来源抗菌肽对一系列人体病原体的评估。
Microbiol Spectr. 2022 Feb 23;10(1):e0166421. doi: 10.1128/spectrum.01664-21. Epub 2022 Jan 5.
6
The characteristics and roles of antimicrobial peptides as potential treatment for antibiotic-resistant pathogens: a review.抗菌肽作为抗生素耐药病原体潜在治疗方法的特性与作用:综述
PeerJ. 2021 Dec 14;9:e12193. doi: 10.7717/peerj.12193. eCollection 2021.
7
Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications.抗菌肽——作用机制、抗菌效果及临床应用
Antibiotics (Basel). 2022 Oct 16;11(10):1417. doi: 10.3390/antibiotics11101417.
8
No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection.没有为老抗生素准备的国家!抗菌肽 (AMPs) 作为治疗皮肤和软组织感染的下一代疗法。
Int J Pharm. 2023 Jul 25;642:123169. doi: 10.1016/j.ijpharm.2023.123169. Epub 2023 Jun 23.
9
In pursuit of next-generation therapeutics: Antimicrobial peptides against superbugs, their sources, mechanism of action, nanotechnology-based delivery, and clinical applications.追求下一代治疗方法:针对超级细菌的抗菌肽、它们的来源、作用机制、基于纳米技术的递药系统以及临床应用。
Int J Biol Macromol. 2022 Oct 1;218:135-156. doi: 10.1016/j.ijbiomac.2022.07.103. Epub 2022 Jul 20.
10
The revitalization of antimicrobial peptides in the resistance era.在耐药时代重新启用抗菌肽。
Pharmacol Res. 2021 Jan;163:105276. doi: 10.1016/j.phrs.2020.105276. Epub 2020 Nov 5.

引用本文的文献

1
Antibacterial Effect of Sesame Protein-Derived Peptides against and : In Silico and In Vitro Analysis.芝麻蛋白源肽对 和 的抑菌作用:计算机模拟和体外分析。
Nutrients. 2024 Jan 4;16(1):175. doi: 10.3390/nu16010175.

本文引用的文献

1
The European Union One Health 2020 Zoonoses Report.《欧盟2020年“同一健康”人畜共患病报告》
EFSA J. 2021 Dec 13;19(12):e06971. doi: 10.2903/j.efsa.2021.6971. eCollection 2021 Dec.
2
Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles.葡聚糖载体制备合成肽保护小鼠免受实验性隐球菌病。
mBio. 2021 Feb 22;13(1):e0336721. doi: 10.1128/mbio.03367-21. Epub 2022 Jan 4.
3
COVID-19 and Influenza coinfection: The rise of Ômicron and H3N2 in Brazil - 2022.2022年巴西新冠病毒与流感合并感染:奥密克戎和H3N2毒株感染率上升
Travel Med Infect Dis. 2022 Mar-Apr;46:102262. doi: 10.1016/j.tmaid.2022.102262. Epub 2022 Jan 14.
4
A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans.从出芽酵母 GAPDH 中分离的一种肽作为一种有前途的抗新型隐球菌的抗真菌剂。
Microbiol Spectr. 2022 Feb 23;10(1):e0082621. doi: 10.1128/spectrum.00826-21. Epub 2022 Jan 12.
5
Antiviral peptides against the main protease of SARS-CoV-2: A molecular docking and dynamics study.针对新型冠状病毒主要蛋白酶的抗病毒肽:分子对接与动力学研究。
Arab J Chem. 2021 Sep;14(9):103315. doi: 10.1016/j.arabjc.2021.103315. Epub 2021 Jul 14.
6
Lipid Transfer Proteins (LTPs)-Structure, Diversity and Roles beyond Antimicrobial Activity.脂质转移蛋白(LTPs)——结构、多样性及抗菌活性之外的作用
Antibiotics (Basel). 2021 Oct 21;10(11):1281. doi: 10.3390/antibiotics10111281.
7
Antifungal Activity of ToAP2D Peptide Against .ToAP2D肽对……的抗真菌活性
Front Bioeng Biotechnol. 2021 Oct 21;9:761518. doi: 10.3389/fbioe.2021.761518. eCollection 2021.
8
Pandemics- One Health preparedness for the next.大流行——为应对下一次大流行的“同一健康”准备工作。
Lancet Reg Health Eur. 2021 Oct;9:100210. doi: 10.1016/j.lanepe.2021.100210. Epub 2021 Oct 7.
9
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.抗真菌药物管线上的药物:福沙那韦、依柏西普、奥洛福康唑、泊沙康唑和瑞他康唑。
Drugs. 2021 Oct;81(15):1703-1729. doi: 10.1007/s40265-021-01611-0. Epub 2021 Oct 9.
10
Genetic and Antigenic Characterization of an Influenza A(H3N2) Outbreak in Cambodia and the Greater Mekong Subregion during the COVID-19 Pandemic, 2020.2020 年 COVID-19 大流行期间柬埔寨和大湄公河次区域流感 A(H3N2)暴发的遗传和抗原特征
J Virol. 2021 Nov 23;95(24):e0126721. doi: 10.1128/JVI.01267-21. Epub 2021 Sep 29.